SCHEMBL6469593

SCHEMBL6469593

Cc1c(Br)c(C)n(Cc2ccc(F)cc2)c1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MITF O75030 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4E B2RXH2 4/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
THRB P10828 1/20 0.42
NR4A1 P22736 1/20 0.42
APEX1 P27695 1/20 0.42
APOBEC3A P31941 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469416 0.84 MAPT (0.51) MAPTALDH1A1HTTRAB9AKDM4E
SCHEMBL7052030 0.75 AR (0.45) MAPTALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL6466727 0.74 AR (0.60) MAPTALDH1A1MITFHTTRAB9A
SCHEMBL6469739 0.72 AR (0.52) MAPTALDH1A1HTTRAB9AKDM4E
SCHEMBL6469264 0.71 MAPT (0.46) MAPTALDH1A1MITFHTTRAB9A
SCHEMBL25062489 0.71 NOTUM (0.75) MAPTALDH1A1MITFHTTRAB9A
SCHEMBL21332975 0.70 POLB (0.44) MAPTALDH1A1MITFHTTRAB9A
SCHEMBL9736726 0.69 PTGES2 (0.67) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL2161402 0.68 MAPT (0.67) MAPTMEN1POLBKMT2ATP53
SCHEMBL5253579 0.68 HTT (0.37) MAPTALDH1A1HTTKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101657-A1 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2005-05-12 US disclosed
EP-1466902-A1 ANDROGEN RECEPTOR ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101657-A1 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative SHBG, PRLHR, FSHR MAPT 4864/4885ALDH1A1 2144/4885MITF 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.